Key opinion leader (KOL): what one is, how to find one and how to interview them

A key opinion leader (KOL) is a person whose view on a particular subject shapes what others in that field think and do. In medicine, that might be a physician whose papers and conference talks change how colleagues treat a condition, or a surgeon other surgeons call before trying a new device. The term is most common in drug and medical device companies, which ask KOLs to advise on research, help design studies and explain new evidence to other clinicians. Investors, startups and B2B marketers use it more loosely, for the people whose recommendations a market tends to follow.

For research, a narrow definition works best: a KOL is someone whose judgment on your specific question carries weight with the people you need to persuade. The idea comes from communication research. Paul Lazarsfeld and Elihu Katz's two-step flow theory described opinion leaders as people who interpret information for others, and opinion leadership is usually treated as specific to one field, so a leader in one area can be a follower in another. Wikipedia: Opinion leadership A cardiologist who leads opinion on heart failure may have little to say about a wound-care product.

How a KOL differs from other experts

A subject matter expert knows a topic well. A KOL knows it and is also listened to. For most projects you need both, and they are often different people. A nurse who changes wound dressings every day may know more about what fails at the bedside than the professor who wrote the treatment guideline. The professor knows which evidence will persuade other clinicians. Ask each about the part they know.

A worked example: a wound-care sensor

Suppose a five-person startup has built a sensor that sits inside a wound dressing and flags early signs of infection in diabetic foot ulcers. The company and details are hypothetical. Before designing a pilot study, the team wants to learn three things:

1. How clinicians decide today when a wound needs more aggressive treatment.
2. What a study would have to measure to persuade other specialists.
3. What a hospital needs before it will buy and use a new device.

Those questions point to three groups:

• Academic KOLs: physicians and podiatrists who publish on diabetic foot ulcers, run trials or sit on guideline committees. They answer question 2.
• Practitioners: wound-care nurses and clinic managers who see these patients daily. They answer question 1.
• Buyers and reviewers: hospital supply chain, value analysis and IT staff. They answer question 3. How to interview B2B users, buyers and champions covers this group.

How to find key opinion leaders in public records

Look for evidence of influence rather than titles or self-description.

• Publications. PubMed is free and contains more than 40 million citations and abstracts of biomedical literature. PubMed Search your condition and note who appears repeatedly as an author on recent studies, reviews and guidelines.
• Clinical trials. Each ClinicalTrials.gov record shows what is being studied, where the study is being conducted and who to contact. The sponsor or investigator supplies the information. NLM fact sheet Investigators running trials in your condition know the current evidence and the practical difficulties of studying it.
• Advisory committees. The FDA uses committees and panels to get independent expert advice on scientific, technical and policy matters, and publishes rosters and meeting materials for each committee, including the device panels. FDA advisory committees
• Industry relationships. CMS's Open Payments program publishes a searchable database of payments that drug and device companies report making to covered recipients such as physicians. Its Program Year 2025 data covers 17.07 million records totaling $14.67 billion. CMS Open Payments Payment categories include consulting fees, which CMS describes as payments for advice and expertise about a medical product or treatment, usually under a written agreement. Natures of payment A physician who already consults for several device companies is likely a recognized KOL. Those relationships matter before you ask for an opinion of a competitor's product. CMS says it does not comment on which relationships are beneficial or conflicts of interest; the data is open to interpretation.

Put the names in a short table: the evidence of influence, how closely their work matches your question, known industry ties, and which group they belong to. Twenty names is plenty for a first pass. Pick five whose work is closest to your question, then add practitioners who do the work every day.

How to interview a KOL

Ask about specific cases and decisions. Broad questions tend to get the answer a KOL gives from a conference stage. Useful questions for the wound-care example:

• When did you last change how you manage these wounds, and what made you change?
• What would a device like this have to show before you used it on your patients? What should a study measure, and over what period?
• Which published results do colleagues still argue about?
• What do community clinics do differently from academic centers?
• Who else in your hospital would need to agree before a new device is used?
• If you had this question, who would you call?

The last question often gives you the next three names. Treat each answer as one informed view. KOLs often champion particular approaches, so check what they say against practitioners and data. What to do when experts disagree and how to check interviews against product and market data cover how.

Keep the arrangement clean

Paying clinicians is regulated, and the rules depend on who you are and how the payment is made. This section is general information, not legal advice. If you are a drug or device manufacturer, involve your compliance team or counsel before the first payment.

• Keep research calls separate from speaking or promotional work. The HHS Office of Inspector General's 2020 Special Fraud Alert on speaker programs notes that drug and device companies reported paying nearly $2 billion to healthcare professionals for speaker-related services over three years. It lists warning signs, including paying more than fair market value, paying in a way that takes into account the business a clinician generates, and letting sales or marketing influence who is chosen. The alert also explains that the federal anti-kickback statute makes it a crime to knowingly and willfully pay anything of value to induce or reward referrals or orders of items paid for by federal health care programs, and notes that OIG has warned physicians that a consulting or speaking arrangement with a drug or device company could be an improper inducement. OIG Special Fraud Alert
• Pay for time, set in advance. Agree the fee before the call, base it on fair market value for the time involved, and never connect it to whether the person uses, prescribes or recommends your product. Keep the choice of whom to approach with medical or scientific staff rather than sales.
• Check whether a payment is reportable. The Insights Association explains in a 2014 position paper that the Sunshine Act excludes payments made through a third party when the manufacturer does not know who received them, which is how blinded market research usually works. Insights Association That exclusion depends on the manufacturer not knowing the physician's identity, so ask counsel before a manufacturer pays a named physician directly.
• Plan for safety reports. If your company holds the license for a product the KOL discusses, you may have adverse event reporting duties. Pharmaceutical market research explains the industry guidelines.
• Disclose paid relationships in marketing. If you later quote a paid KOL publicly, the FTC's Endorsement Guides say a connection that might materially affect how much weight the audience gives an endorsement, such as payment, must be disclosed clearly and conspicuously when the audience would not expect it. One of the FTC's examples is a physician paid to post about a product on social media. 16 CFR 255.5

Key opinion leaders outside healthcare

The same method works in other markets. In B2B software, the people whose views spread may be practitioners who write and speak about their work, organizers of professional communities, or former operators who now advise many companies. Look for the evidence: who peers cite, who is asked to speak, whose templates others copy. Then check whether their experience matches your question. A KOL often shapes which vendors make a shortlist without being the person who signs, so pair them with interviews of the people who actually buy.

Your next step

Write the one question you need a KOL to answer and the group whose opinion matters, such as surgeons, prescribers or hospital buyers. Pull 20 names from PubMed and ClinicalTrials.gov, look each one up in Open Payments, and choose five whose work fits the question best. Then add three practitioners who do the work every day.

If you need people who rarely appear in publications, such as wound-care nurses or hospital supply chain staff, Instant Expert can find people who match a description you write. You review who it finds, it sends your invitations, and you pay only for calls that get booked. The directory pages for hospital supply chain experts and medical device consultants are one place to start.